机译:全球性质更新人流感病毒对神经氨酸酶抑制剂的易感性,2015-2016
WHO Collaborating Center for Surveillance Epidemiology and Control of Influenza Centers for;
Global Influenza Programme World Health Organization;
The Francis Crick Institute Worldwide Influenza Centre (WIC) WHO Collaborating Centre for;
WHO Collaborating Center for Surveillance Epidemiology and Control of Influenza Centers for;
The Francis Crick Institute Worldwide Influenza Centre (WIC) WHO Collaborating Centre for;
WHO Collaborating Centre for Reference and Research on Influenza National Institute for Viral;
WHO Collaborating Centre for Reference and Research on Influenza At the Peter Doherty Institute;
WHO Collaborating Center for Surveillance Epidemiology and Control of Influenza Centers for;
National Infection Service Public Health England;
WHO Collaborating Centre for Reference and Research on Influenza At the Peter Doherty Institute;
Public Health Laboratory Centre;
Division of Health Emergencies and Communicable Diseases World Health Organization Regional Office;
Influenza Pathogenesis and Antiviral Resistance Laboratory National Institute of Health;
National Influenza Center Laboratorio de Virus Respiratorios Oswaldo Cruz Institute/FIOCRUZ;
WHO Collaborating Centre for Reference and Research on Influenza National Institute of Infectious;
WHO Collaborating Centre for Reference and Research on Influenza National Institute of Infectious;
WHO Collaborating Centre for Reference and Research on Influenza National Institute for Viral;
Global Influenza Programme World Health Organization;
National Institute for Public Health and the Environment;
Neuraminidase; Inhibitor; Susceptibility; Surveillance; Resistance; Markers;
机译:全球性质更新人流感病毒对神经氨酸酶抑制剂的易感性,2015-2016
机译:2014-2015年全球人类流感病毒对神经氨酸酶抑制剂敏感性的最新动态
机译:全球关于人流感病毒对神经酰胺酶抑制剂的敏感性的最新性和涵盖型内切核酸酶抑制剂Baloxavir,2017-2018
机译:神经氨酸氨基酶的不敏感唾液酸衍生物,用于检测和抑制流感病毒糖蛋白和完整病毒的抑制作用
机译:抗神经氨酸酶抑制剂的甲型流感病毒适应性和传播性的分子基础
机译:2015-2016年全球人类流感病毒对神经氨酸酶抑制剂敏感性的最新动态
机译:2014-2015年全球人类流感病毒对神经氨酸酶抑制剂敏感性的最新动态